Ernexa Therapeutics Inc. Warrants
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the tr… Read more
Market Cap & Net Worth: Ernexa Therapeutics Inc. Warrants (ERNAW)
Ernexa Therapeutics Inc. Warrants (NASDAQ:ERNAW) has a market capitalization of $355.03 ($355.03) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #49192 globally and #15084 in its home market, demonstrating a -61.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ernexa Therapeutics Inc. Warrants's stock price $0.04 by its total outstanding shares 9343 (9.34K).
Ernexa Therapeutics Inc. Warrants Market Cap History: 2026 to 2026
Ernexa Therapeutics Inc. Warrants's market capitalization history from 2026 to 2026. Data shows growth from $355.03 to $355.03 (0.00% CAGR).
Ernexa Therapeutics Inc. Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ernexa Therapeutics Inc. Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ERNAW by Market Capitalization
Companies near Ernexa Therapeutics Inc. Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to Ernexa Therapeutics Inc. Warrants by market ranking:
- Odel PLC (CM:ODELN0000): Ranked #49183 globally with a market cap of $357.90 USD ( SLRs104.40K LKR).
- Zitto Inc (PINK:ZTTO): Ranked #49184 globally with a market cap of $357.74 USD.
- ORIENTAL PRESS GRP (MU:OPQ): Ranked #49193 globally with a market cap of $353.79 USD ( €344.66 EUR).
- SAMBA FOODS LIMITED (GSE:SAMBA): Ranked #49194 globally with a market cap of $353.07 USD ( GH₵5.21K GHS).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #49183 | Odel PLC | CM:ODELN0000 | $357.90 | SLRs11.50 |
| #49184 | Zitto Inc | PINK:ZTTO | $357.74 | $0.04 |
| #49193 | ORIENTAL PRESS GRP | MU:OPQ | $353.79 | €0.04 |
| #49194 | SAMBA FOODS LIMITED | GSE:SAMBA | $353.07 | GH₵0.55 |
Ernexa Therapeutics Inc. Warrants Historical Marketcap From 2026 to 2026
Between 2026 and today, Ernexa Therapeutics Inc. Warrants's market cap moved from $355.03 to $ 355.03, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $355.03 | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Ernexa Therapeutics Inc. Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $355.03 USD |
| MoneyControl | $355.03 USD |
| MarketWatch | $355.03 USD |
| marketcap.company | $355.03 USD |
| Reuters | $355.03 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.